Assessment of oxygen uptake during the 6-minute walking test in patients with heart failure: Preliminary experience with a portable device

被引:108
作者
Faggiano, P
DAloia, A
Gualeni, A
Lavatelli, A
Giordano, A
机构
[1] IRCCS,SALVATORE MAUGERI FDN,DIV CARDIOL,GUSSAGO,ITALY
[2] FORNITURE MED,MI LA,MILAN,ITALY
关键词
D O I
10.1016/S0002-8703(97)70125-X
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
In patients with heart failure, the 6-minute walking test (6-MWT) is considered a useful measure of submaximal exercise capacity, Few data are available on oxygen uptake (VO2) during a standard 6-MWT. The aim of this study was to measure the 6-MWT VO2 by using a recently validated portable instrument in 26 patients (24 men, 2 women; mean age, 56 +/- 11 years) with mild to severe heart failure (New York Heart Association class II, 10 patients; III, 10 patients; IV, 6 patients; left ventricular ejection fraction: 22 +/- 6%). Peak VO2 was measured during a symptom-limited cardiopulmonary exercise test performed in a period of 1 to 3 days (10 watt/m increment). Peak VO2 was 15 +/- 4 ml/kg/m during the symptom-limited test and 12.9 +/- 4.4 ml/kg/m during the 6-MWT (p < 0.05), corresponding to 86% of peak VO2. Seven (27%) of 26 patients showed a 6-MWT VO2 equal to or higher than peak VO2. Anaerobic threshold (AT) was identified in 23 of 26 patients during maximal exercise and in 19 of 26 patients during the 6-MWT; VO2 at AT was similar in the two tests (12.2 +/- 3.5 ml/kg/m vs 11.9 +/- 4.2 ml/kg/m). The distance walked during the 6-MWT (mean, 418 +/- 20 m) significantly correlated with 6-MWT VO2 (r = 0.71) and peak VO2 (r = 0.63); the 6-MWT VO2 also showed a high correlation with peak VO2 (r = 0.86). Thus in patients with failing hearts, VO2 during 6-MWT (considered a classic submaximal exercise) is, on average, only 15% tower than peak VO2 and is largely supported by anaerobic metabolism (work above the anaerobic threshold).
引用
收藏
页码:203 / 206
页数:4
相关论文
共 9 条
[1]  
[Anonymous], PRINCIPLES EXERCISE
[2]   PREDICTION OF MORTALITY AND MORBIDITY WITH A 6-MINUTE WALK TEST IN PATIENTS WITH LEFT-VENTRICULAR DYSFUNCTION [J].
BITTNER, V ;
WEINER, DH ;
YUSUF, S ;
ROGERS, WJ ;
MCINTYRE, KM ;
BANGDIWALA, SI ;
KRONENBERG, MW ;
KOSTIS, JB ;
KOHN, RM ;
GUILLOTTE, M ;
GREENBERG, B ;
WOODS, PA ;
BOURASSA, MG .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1993, 270 (14) :1702-1707
[3]   The six-minute walk test predicts peak oxygen uptake and survival in patients with advanced heart failure [J].
Cahalin, LP ;
Mathier, MA ;
Semigran, MJ ;
Dec, GW ;
DiSalvo, TG .
CHEST, 1996, 110 (02) :325-332
[4]  
FEBO O, 1995, CONGESTIVE HEART FAI
[5]  
FORAY A, 1996, CIRCULATION S, V2, P222
[6]  
GUYATT GH, 1985, CAN MED ASSOC J, V132, P919
[7]   6 MINUTE WALKING TEST FOR ASSESSING EXERCISE CAPACITY IN CHRONIC HEART-FAILURE [J].
LIPKIN, DP ;
SCRIVEN, AJ ;
CRAKE, T ;
POOLEWILSON, PA .
BRITISH MEDICAL JOURNAL, 1986, 292 (6521) :653-655
[8]   The effect of carvedilol on morbidity and mortality in patients with chronic heart failure [J].
Packer, M ;
Bristow, MR ;
Cohn, JN ;
Colucci, WS ;
Fowler, MB ;
Gilbert, EM ;
Shusterman, NH .
NEW ENGLAND JOURNAL OF MEDICINE, 1996, 334 (21) :1349-1355
[9]   OXYGEN-CONSUMPTION DURING CORRIDOR WALK TESTING IN CHRONIC CARDIAC-FAILURE [J].
RILEY, M ;
MCPARLAND, J ;
STANFORD, CF ;
NICHOLLS, DP .
EUROPEAN HEART JOURNAL, 1992, 13 (06) :789-793